What is the P/S ratio for Medline Inc. (MDLN)?

The P/S ratio for MDLN stock is 1.10.

Is Medline Inc.'s P/S ratio high or low?

The P/S ratio of 1.10 is in line with its 1-year average of 1.20, around the middle of its 1-year range (0.94–1.43).

Medline (MDLN) Price/Sales Ratio: History & Chart

Compare

Medline Inc. (MDLN)MDLNMedline Inc.

Compare

About Medline Inc.

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Northfield, IL

45,000 employees

www.medline.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: James Boyle

View full financials

MDLN PS Ratio Metrics

PS RATIO

1.10

PS RATIO AVG TTM

N/A

PS RATIO AVG 3Y

N/A

PS RATIO AVG 5Y

N/A

PS RATIO AVG 10Y

N/A

PS RATIO AVG 15Y

N/A

PS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.24

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

-66.05%

vs the sector median at left

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Medline Inc. (MDLN)	$32.77B	1.10	N/A	N/A	N/A
Zoetis Inc. (ZTS)vs ›	$31.59B	3.35	5.60	7.94	9.12
Centene Corp. (CNC)vs ›	$31.31B	0.16	0.11	0.19	0.25
IQVIA Holdings Inc. (IQV)vs ›	$34.72B	2.12	2.08	2.38	2.67
Biogen Inc. (BIIB)vs ›	$29.85B	3.04	2.57	2.81	3.10
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$36.28B	8.76	15.99	15.07	19.32
ResMed Inc. (RMD)vs ›	$28.33B	5.18	6.74	6.65	7.89
DexCom, Inc. (DXCM)vs ›	$27.61B	5.84	6.15	9.35	13.06
GE HealthCare Technologies Inc. (GEHC)vs ›	$27.56B	1.39	1.69	1.80	1.81
Mettler-Toledo International Inc. (MTD)vs ›	$26.82B	6.58	6.77	6.93	7.57

NAME

MARKET CAP

PS RATIO

TTM

Medline Inc. (MDLN)

$32.77B

1.10

N/A

Zoetis Inc. (ZTS)vs ›

$31.59B

3.35

5.60

7.94

9.12

Centene Corp. (CNC)vs ›

$31.31B

0.16

0.11

0.19

0.25

IQVIA Holdings Inc. (IQV)vs ›

$34.72B

2.12

2.08

2.38

2.67

Biogen Inc. (BIIB)vs ›

$29.85B

3.04

2.57

2.81

3.10

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$36.28B

8.76

15.99

15.07

19.32

ResMed Inc. (RMD)vs ›

$28.33B

5.18

6.74

6.65

7.89

DexCom, Inc. (DXCM)vs ›

$27.61B

5.84

6.15

9.35

13.06

GE HealthCare Technologies Inc. (GEHC)vs ›

$27.56B

1.39

1.69

1.80

1.81

Mettler-Toledo International Inc. (MTD)vs ›

$26.82B

6.58

6.77

6.93

7.57

DATE	PS RATIO
2026-07-24	1.10
2026-07-23	1.07
2026-07-22	1.05
2026-07-21	1.11
2026-07-20	1.10
2026-07-17	1.13
2026-07-16	1.16
2026-07-15	1.12
2026-07-14	1.09
2026-07-13	1.15
2026-07-10	1.16
2026-07-09	1.16
2026-07-08	1.14
2026-07-07	1.22
2026-07-06	1.21
2026-07-02	1.22
2026-07-01	1.18
2026-06-30	1.12
2026-06-29	1.12
2026-06-26	1.10
2026-06-25	1.07
2026-06-24	1.02
2026-06-23	1.00
2026-06-22	0.98
2026-06-18	1.02
2026-06-17	1.03
2026-06-16	1.05
2026-06-15	1.06
2026-06-12	1.04
2026-06-11	1.05
2026-06-10	1.03
2026-06-09	1.02
2026-06-08	0.96
2026-06-05	0.95
2026-06-04	0.98
2026-06-03	0.98
2026-06-02	0.94
2026-06-01	1.01
2026-05-29	1.04
2026-05-28	1.04
2026-05-27	1.01
2026-05-26	1.02
2026-05-22	1.05
2026-05-21	1.05
2026-05-20	1.03
2026-05-19	1.07
2026-05-18	1.02
2026-05-15	1.02
2026-05-14	1.10
2026-05-13	1.10
2026-05-12	1.09
2026-05-11	1.11
2026-05-08	1.12
2026-05-07	1.19
2026-05-06	1.19
2026-05-05	1.28
2026-05-04	1.25
2026-05-01	1.27
2026-04-30	1.26
2026-04-29	1.23
2026-04-28	1.25
2026-04-27	1.28
2026-04-24	1.27
2026-04-23	1.31
2026-04-22	1.34
2026-04-21	1.35
2026-04-20	1.37
2026-04-17	1.35
2026-04-16	1.33
2026-04-15	1.36
2026-04-14	1.35
2026-04-13	1.34
2026-04-10	1.29
2026-04-09	1.29
2026-04-08	1.26
2026-04-07	1.22
2026-04-06	1.24
2026-04-02	1.25
2026-04-01	1.25
2026-03-31	1.26
2026-03-30	1.21
2026-03-27	1.18
2026-03-26	1.21
2026-03-25	1.22
2026-03-24	1.20
2026-03-23	1.21
2026-03-20	1.22
2026-03-19	1.24
2026-03-18	1.21
2026-03-17	1.20
2026-03-16	1.19
2026-03-13	1.18
2026-03-12	1.17
2026-03-11	1.21
2026-03-10	1.22
2026-03-09	1.24
2026-03-06	1.25
2026-03-05	1.26
2026-03-04	1.22
2026-03-03	1.27
2026-03-02	1.31
2026-02-27	1.36
2026-02-26	1.40
2026-02-25	1.38
2026-02-24	1.43
2026-02-23	1.42
2026-02-20	1.42
2026-02-19	1.36
2026-02-18	1.36
2026-02-17	1.32
2026-02-13	1.27
2026-02-12	1.27
2026-02-11	1.29
2026-02-10	1.29
2026-02-09	1.35
2026-02-06	1.35
2026-02-05	1.32
2026-02-04	1.28
2026-02-03	1.28
2026-02-02	1.29
2026-01-30	1.26
2026-01-29	1.25
2026-01-28	1.27
2026-01-27	1.32
2026-01-26	1.28
2026-01-23	1.31
2026-01-22	1.31
2026-01-21	1.24
2026-01-20	1.26
2026-01-16	1.26
2026-01-15	1.22
2026-01-14	1.24
2026-01-13	1.22
2026-01-12	1.22
2026-01-09	1.16
2026-01-08	1.18
2026-01-07	1.15
2026-01-06	1.14
2026-01-05	1.11
2026-01-02	1.16
2025-12-31	1.20
2025-12-30	1.22
2025-12-29	1.22
2025-12-26	1.28
2025-12-24	1.29
2025-12-23	1.27
2025-12-22	1.23
2025-12-19	1.21
2025-12-18	1.15
2025-12-17	1.19

DATE

PS RATIO

2026-07-24

1.10

2026-07-23

1.07

2026-07-22

1.05

2026-07-21

1.11

2026-07-20

1.10

2026-07-17

1.13

2026-07-16

1.16

2026-07-15

1.12

2026-07-14

1.09

2026-07-13

1.15

2026-07-10

1.16

2026-07-09

1.16

2026-07-08

1.14

2026-07-07

1.22

2026-07-06

1.21

2026-07-02

1.22

2026-07-01

1.18

2026-06-30

1.12

2026-06-29

1.12

2026-06-26

1.10

2026-06-25

1.07

2026-06-24

1.02

2026-06-23

1.00

2026-06-22

0.98

2026-06-18

1.02

2026-06-17

1.03

2026-06-16

1.05

2026-06-15

1.06

2026-06-12

1.04

2026-06-11

1.05

2026-06-10

1.03

2026-06-09

1.02

2026-06-08

0.96

2026-06-05

0.95

2026-06-04

0.98

2026-06-03

0.98

2026-06-02

0.94

2026-06-01

1.01

2026-05-29

1.04

2026-05-28

1.04

2026-05-27

1.01

2026-05-26

1.02

2026-05-22

1.05

2026-05-21

1.05

2026-05-20

1.03

2026-05-19

1.07

2026-05-18

1.02

2026-05-15

1.02

2026-05-14

1.10

2026-05-13

1.10

2026-05-12

1.09

2026-05-11

1.11

2026-05-08

1.12

2026-05-07

1.19

2026-05-06

1.19

2026-05-05

1.28

2026-05-04

1.25

2026-05-01

1.27

2026-04-30

1.26

2026-04-29

1.23

2026-04-28

1.25

2026-04-27

1.28

2026-04-24

1.27

2026-04-23

1.31

2026-04-22

1.34

2026-04-21

1.35

2026-04-20

1.37

2026-04-17

1.35

2026-04-16

1.33

2026-04-15

1.36

2026-04-14

1.35

2026-04-13

1.34

2026-04-10

1.29

2026-04-09

1.29

2026-04-08

1.26

2026-04-07

1.22

2026-04-06

1.24

2026-04-02

1.25

2026-04-01

1.25

2026-03-31

1.26

2026-03-30

1.21

2026-03-27

1.18

2026-03-26

1.21

2026-03-25

1.22

2026-03-24

1.20

2026-03-23

1.21

2026-03-20

1.22

2026-03-19

1.24

2026-03-18

1.21

2026-03-17

1.20

2026-03-16

1.19

2026-03-13

1.18

2026-03-12

1.17

2026-03-11

1.21

2026-03-10

1.22

2026-03-09

1.24

2026-03-06

1.25

2026-03-05

1.26

2026-03-04

1.22

2026-03-03

1.27

2026-03-02

1.31

2026-02-27

1.36

2026-02-26

1.40

2026-02-25

1.38

2026-02-24

1.43

2026-02-23

1.42

2026-02-20

1.42

2026-02-19

1.36

2026-02-18

1.36

2026-02-17

1.32

2026-02-13

1.27

2026-02-12

1.27

2026-02-11

1.29

2026-02-10

1.29

2026-02-09

1.35

2026-02-06

1.35

2026-02-05

1.32

2026-02-04

1.28

2026-02-03

1.28

2026-02-02

1.29

2026-01-30

1.26

2026-01-29

1.25

2026-01-28

1.27

2026-01-27

1.32

2026-01-26

1.28

2026-01-23

1.31

2026-01-22

1.31

2026-01-21

1.24

2026-01-20

1.26

2026-01-16

1.26

2026-01-15

1.22

2026-01-14

1.24

2026-01-13

1.22

2026-01-12

1.22

2026-01-09

1.16

2026-01-08

1.18

2026-01-07

1.15

2026-01-06

1.14

2026-01-05

1.11

2026-01-02

1.16

2025-12-31

1.20

2025-12-30

1.22

2025-12-29

1.22

2025-12-26

1.28

2025-12-24

1.29

2025-12-23

1.27

2025-12-22

1.23

2025-12-19

1.21

2025-12-18

1.15

2025-12-17

1.19

PS Ratio: 1.10

MDLN PS Ratio Chart

MDLN PS Ratio Metrics

MDLN Competitors' PS Ratio

P/S vs. its own history

Sales Valuation

PS Ratio Formula & Definition

PS Ratio FAQ

MDLN PS Ratio History

Related Metrics